Blog
RSS FeedPosted by Michael Wonder on 03 Sep 2018
Clark accused of cronyism over PHARMAC appointment
1 September 2018 - David Clark is faced with allegations of cronyism after appointing former Labour MP Steve Maharey chair ...
Posted by Michael Wonder on 03 Sep 2018
Patients wanting special funding for anti-depressants turned down by PHARMAC
2 September 2018 - Last year, PHARMAC stopped subsidising two brands of anti-depressants, Arrow Venlafaxine and Effexor XR, and replaced them ...
Posted by Michael Wonder on 31 Aug 2018
New Zealand Pharmaceutical Schedule - 1 September 2018 update
1 September 2018 - The September 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Aug 2018
Expensive life-prolonging drug not an option for many women
30 August 2018 - Wiki Mulholland has the toughest of balancing acts – between staying alive and draining her family ...
Posted by Michael Wonder on 30 Aug 2018
Woman's desperate plea to PHARMAC to fund $6,000/month cancer drug
31 august 2018 - A New Zealand woman is pleading with pharmaceutical giant PHARMAC and MPs to fund an expensive ...
Posted by Michael Wonder on 30 Aug 2018
Proposal to list sapropterin for use in pregnancy by women with phenylketonuria
30 August 2018 - PHARMAC is seeking feedback on a proposal to fund sapropterin tablets, a treatment for the rare ...
Posted by Michael Wonder on 27 Aug 2018
Battling cancer and fighting for funding
28 August 2018 - Dr Rosalie Stephens turns up to work these days with hope. ...
Posted by Michael Wonder on 27 Aug 2018
Update on proposal to fund a pangenotypic hepatitis C treatment - glecaprevir and pibrentasvir (Maviret)
27 August 2018 - PHARMAC would like to thank everyone who provided feedback on a proposal to fund glecaprevir and ...
Posted by Michael Wonder on 21 Aug 2018
Proposal to change the funded brand of epoetin alfa
21 August 2018 - PHARMAC is seeking feedback on a proposed change to the funded brand of epoetin alfa [erythropoietin ...
Posted by Michael Wonder on 20 Aug 2018
Treatment funded in Australia, but New Zealand brother misses out
21 August 2018 - James McGoram says the genetic disease he has is yet to affect his day-to-day life but ...
Posted by Michael Wonder on 20 Aug 2018
Proposal to list nintedanib (Ofev) and remove restrictions from tiotropium bromide (Spiriva)
20 August 2018 - PHARMAC is seeking feedback on a proposal to list nintedanib (Ofev) and remove the current funding ...
Posted by Michael Wonder on 14 Aug 2018
PHARMAC funding of MS drugs "restrictive & cruel"
14 August 2018 - An Australian neurologist says the way PHARMAC's criteria for continuing access to drugs for multiple sclerosis ...
Posted by Michael Wonder on 13 Aug 2018
Declining HIV numbers bolstered by new prevention drug but more data needed
13 August 2018 - PHARMAC's decision earlier this year to fund anti-retroviral drug Truvada as a preventive treatment was hailed ...
Posted by Michael Wonder on 13 Aug 2018
MS patient tells of stress of meeting PHARMAC criteria
14 August 2018 - When Auckland man Brendan Rochford stopped being able to walk 500 m unaided, he lost his ...
Posted by Michael Wonder on 13 Aug 2018
Breast cancer sufferer calls for life-saving Kadcyla drug to be publicly funded
13 August 2018 - A cancer sufferer is calling for PHARMAC to fund a potentially life-saving drug. ...